JEFFREY MITCHELL is listed as an executive officer on 7 SEC Form D filings by 1 issuer between Apr 2019 and Nov 2022: LexaGene Holdings Inc. (Beverly, MA — biotechnology — 2019–2022; $5M reported sold to 19 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 SEC release, 6 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 7 public filings for JEFFREY MITCHELL and found 7 differences, 1 worth asking the sponsor about: Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.